YFYonghong Feng

Yonghong Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yonghong Feng has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Guanghong Yang

    Guizhou Provincial Center for Disease Control and Prevention

    2 shared publications
  • Jin Huang

    Key Laboratory of Environment Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang, China

    2 shared publications
  • Xiaochen Huang

    Key Laboratory of Environment Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang, China

    2 shared publications
  • Adiilah K. Soodeen-Lalloo

    Department of Radiology, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China

    1 shared publication
  • Chunyan Min

    Key Laboratory of Environment Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang, China

    1 shared publication
  • Fengfang Chen

    Shanghai Key Laboratory of Tuberculosis, School of Medicine, Clinical and Research Centre of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Global, regional, and national burden of chronic respiratory diseases among perimenopausal women, 1990–2021: an analysis for the Global Burden of Disease Study 2021

    by Lixiuyun Wang, Yafei Tang, Zixiang Ji, Guoqiang Yang, Jin Huang, Yonghong Feng

    Perimenopausal women face a range of health issues, yet there is a lack of systematic overview regarding their pulmonary health. We aimed to assess the burden, risk factors, and cross-country inequality of chronic respiratory diseases (CRDs) in perimenopausal women from 1990 to 2021. Based on the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we assessed the age-standardized incidence rate (ASIR), prevalence rate (ASPR), mortality rate (ASMR), and disability-adjusted life year rate (ASDR) for CRDs (1990–2021). Trends were analyzed using Joinpoint regression, correlations with Pearson’s method, and inequalities using the Slope Index of Inequality (SII) and the Concentration Index (CIX). Risk factors for CRDs were analyzed from exposure data. In 2021, CRDs were responsible for 2.11 million new cases, resulting in 3.97 million disability-adjusted life years (DALYs) in perimenopausal women. Chronic obstructive pulmonary disease (COPD), with 1.1 (0.8–1.4) million incidence cases, had the highest ASIR and ASMR. With 14.1 (11.4–17.2) million prevalent cases, asthma had the highest prevalence among CRDs. The rates of interstitial lung disease and pulmonary sarcoidosis had slightly increased. The ASDRs of COPD, pneumoconiosis and asthma were negatively correlated with the socio-demographic index (SDI). There were significant health inequalities across 204 countries and territories. Particulate matter pollution is the greatest risk factor for CRDs. CRDs caused heavy burdens and deaths. Some risk factors (environmental pollution, high BMI and tobacco use) need to be urgently managed and improved, especially in areas with low and low-middle SDI levels. The correlation between elevated ASIR of ILD and pulmonary sarcoidosis and increasing of SDI needs to be given more attention.


  • Open Access

    Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer

    by Jun Liu, Jingyi Jia, Siqiao Wang, Junfang Zhang, Shuyuan Xian, Zixuan Zheng, Lin Deng, Yonghong Feng, Yuan Zhang, Jie Zhang

    (1) Background: Non-small cell lung cancer (NSCLC) is the most common lung cancer. Enhancer RNA (eRNA) has potential utility in the diagnosis, prognosis and treatment of cancer, but the role of eRNAs in NSCLC metastasis is not clear; (2) Methods: Differentially expressed transcription factors (DETFs), enhancer RNAs (DEEs), and target genes (DETGs) between primary NSCLC and metastatic NSCLC were identified. Prognostic DEEs (PDEEs) were screened by Cox regression analyses and a predicting model for metastatic NSCLC was constructed. We identified DEE interactions with DETFs, DETGs, reverse phase protein arrays (RPPA) protein chips, immunocytes, and pathways to construct a regulation network using Pearson correlation. Finally, the mechanisms and clinical significance were explained using multi-dimensional validation unambiguously; (3) Results: A total of 255 DEEs were identified, and 24 PDEEs were selected into the multivariate Cox regression model (AUC = 0.699). Additionally, the NSCLC metastasis-specific regulation network was constructed, and six key PDEEs were defined (ANXA8L1, CASTOR2, CYP4B1, GTF2H2C, PSMF1 and TNS4); (4) Conclusions: This study focused on the exploration of the prognostic value of eRNAs in the metastasis of NSCLC. Finally, six eRNAs were identified as potential markers for the prediction of metastasis of NSCLC.


  • Open Access

    Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China

    by Hua Quan, Wenhong Wu, Guanghong Yang, Yunlin Wu, Wenlan Yang, Chunyan Min, Jinyun Shi, Lianhua Qin, Jin Huang, Jie Wang, et al.

    Background: Silicosis poses a threat to workers’ health due to the irreversible lung lesions.Design: A retrospective cohort study.Methods: A total of 259 patients [80 worked with artificial stone (AS), 179 with non-artificial stone (non-AS)] with confirmed silicosis were included in this study. Forty-one of AS and 91 of non-AS had approximately 2 years’ follow-up records [lung function tests and high-resolution computer tomography (HRCT)]. Compared with the first records, increased, densified, or newly emerging lesions in lung HRCT images were judged as progression of the disease. Cox proportional hazards models were used to determine the risk factors. Kaplan–Meier survival curve and log-rank test were used to compare prognostic factors for cumulative risk of progression.Results: In 132 patients with median follow-up of 24.0 months (IQR, 13.8, 24.9), 66 patients showed progression, in them, 36 (87.8%) were from AS group and 30 (32.9%) from non-AS group. Working experience of AS processing (hazard ratio, 5.671; 95% CI, 3.048–10.550) and complicated silicosis in CT images (hazard ratio, 2.373; 95% CI, 1.379–4.082) were the main risk factors associated with progression. Forced vital capacity decreased after 1-year (241.5 vs. 55.2 mL) and 2-year (328.1 vs. 68.8 mL) follow-up in the two groups (AS vs. non-AS). History of anti-tuberculosis medication, chest oppression and pain, ground-glass opacity, pleural abnormalities, and restrictive pulmonary dysfunction were more frequently found on HRCT images in the AS group than non-AS group. Lung functions (DLCO, %) were lower in the current/former smokers than the non-smokers (P < 0.05) in AS patients.Conclusion: Prevention and protection rules are needed to be enforced in the occupation involving AS processing; smoking may be associated with declined lung function in AS patients.


  • Open Access

    Sex Disparity in Severity of Lung Lesions in Newly Identified Tuberculosis Is Age-Associated

    by Yue Chu, Adiilah K. Soodeen-Lalloo, Jin Huang, Guanghong Yang, Fengfang Chen, Hongyun Yin, Wei Sha, Xiaochen Huang, Jingyun Shi, Yonghong Feng

    Background: The age-associated characteristic of computed tomography (CT) images of tuberculosis (TB) and the reason for male bias in TB are still not clear. Methods: We compared the CT images, clinical inflammatory indices and sputum bacterial counts between 594 non-smoking men and women with newly diagnosed TB with matched large span of ages from 15 to 92 years old. Logistic regression analyses were used to identify the cavity-associated factors of men and women, separately and in combination. Results: Sputum bacterial counts, ratio of cavities, lung injury scores, and level of C reactive protein were significantly higher in men than in women with ages from 15 to 74, but not in cases older than 75. In CT images, thick walled cavity, cicatricial emphysema and parenchymal bands were present in men at ages of 15–74 more than matched women. Ratios of cases with lobular emphysema and pleural effusion were higher in men after age of 56. While ratios of cases with parenchymal bands, calcification, pleural effusion, pleural thickening, lobular emphysema and bronchovascular distortion increased with aging, those of centrilobular nodules, micronodules and tree in bud decreased with aging in men. Erythrocyte sedimentation rate (ESR) increased with aging, but no differences were found between men and women in ESR or T-SPOT TB tests. Higher complement C4 and lower body mass index in men and positive result in anti-TB antibody test in women were strongly associated with the presence of cavity. Conclusions: The sex bias in TB is age-associated. TB prevention, treatment and research should take differences of sex and age into account.